首页> 外文OA文献 >Busulfan, Cyclophosphamide, Etoposide (BUCYVP) or Carmustine, Etoposide, Cytarabine, Melphelan (BEAM) for Conditioning Prior to Autologous Stem Cell Transplantation (ASCT) in Patients with Hodgkin Lymphoma (HL)?

【2h】

Busulfan, Cyclophosphamide, Etoposide (BUCYVP) or Carmustine, Etoposide, Cytarabine, Melphelan (BEAM) for Conditioning Prior to Autologous Stem Cell Transplantation (ASCT) in Patients with Hodgkin Lymphoma (HL)?

机译：在患有霍奇金淋巴瘤（HL）的患者进行自体干细胞移植（ASCT）之前先进行调理的白消安，环磷酰胺，依托泊苷（BUCYVP）或卡莫司汀，依托泊苷，阿糖胞苷，美菲仑（BEAM）？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Salem G.; Ruppert A.S.; Efebera Y.; Elder P.; Bingman A.; Penza S.; Andritsos L.A.; Devine S.M.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas [J] . Sakellari Ioanna, Mallouri Despoina, Batsis Ioannis, Leukemia and lymphoma . 2015,第11期

机译：卡莫斯汀，依托泊苷，阿糖胞苷和美法仑与自体造血细胞移植的新设计的静脉内以白消安为基础的Busulfex，依托泊苷和美法仑调理方案：晚期霍奇金淋巴瘤和非霍奇金淋巴瘤的回顾性配对分析
2. Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT) [J] . Cashen Amanda, Gosch Kendall, Fletcher Theresa, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：II期无丙二醇美法仑（Evomela）与卡莫司汀，依托泊苷和阿糖胞苷（BEAM）联合用于自体干细胞移植（ASCT）淋巴瘤患者的清髓条件的II期研究
3. BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma [J] . Sakellari Ioanna, Gavriilaki Eleni, Bouziana Stella, Bone marrow transplantation . 2019,第6期

机译：BEAC（Carmustine，eToposide，溶剂胺和环磷酰胺）在自体造血细胞移植中：一种安全有效的霍奇金和非霍奇金淋巴瘤的替代调理方案
4. Correlates of fatigue in lymphoma patients undergoing autologous peripheral blood stem cell transplantation. [D] . El-Banna, Majeda Mohammed. 2004

机译：与进行自体外周血干细胞移植的淋巴瘤患者疲劳相关。
5. BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma [O] . Ana Lucia Ron-Magaña, Omar Eduardo Fernandez-Vargas, Esperanza Barrera-Chairez, 2019

机译：霍奇金和非霍奇金淋巴瘤患者自体造血干细胞移植（HSCT）之前用顺铂+地塞米松代替卡莫司汀进行BEAM改良的条件治疗
6. Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma [O] . CIBMTR, CIBMTR/Medical College of Wisconsin, Milwaukee, WI ( host institution ), Pasquini, Marcelo C. ( author ), Le Rademacher, Jennifer ( author ), 2014

机译：自体造血细胞移植（autoHCT）之前，将白消安/环磷酰胺/依托泊苷（BuCyE）与卡马汀/依托泊苷/阿糖胞苷/美法仑（BEAM）调理方案的配对配对比较

Busulfan, Cyclophosphamide, Etoposide (BUCYVP) or Carmustine, Etoposide, Cytarabine, Melphelan (BEAM) for Conditioning Prior to Autologous Stem Cell Transplantation (ASCT) in Patients with Hodgkin Lymphoma (HL)?

著录项

相似文献

相关主题

期刊订阅